Transaction · 0002114309-26-000007

Xu Cong Claire

Xu Cong Claire, EVP, CD, reported a transaction classified as exercise at NovaBridge Biosciences involving 9382.000000 shares. Reported holdings after the transaction were 307483.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

exerciseSEC transaction code MEVP, CD
NBPNovaBridge Biosciences
Filing timeSep 01
Trade dateAug 30, 2026
Filing · SECView on SEC
InsiderProfile

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
—
Pre-filing
1mo ago1w ago1d ago
Returns since
7d30d90d180d1y

NBP price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
NBP since 2026-09-01Filed 3 days ago · 30 days of pre-filing context shaded
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
exercise
Code M
Identifier
0002114309-26-000007
Ordinary Shares
Transaction date
Aug 30, 2026
Filed Sep 01, 2026, 10:00 PM · 2d delay
Shares
9.38k sh
Price unknown
Estimated value
—
Computed from shares × price
Holdings after
307k sh
Direct

Filing warnings

Notes recorded with this filing
1 warning
missing priceThe filing did not provide a usable price per share.

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $10.0MLarge $100M
Direct Ownership
+2score
Filing-only score

+2

Compact filing score computed from stored Form 4 facts. Version v1.

Neutral filing signal

This filing is broadly neutral on the filing-only scale. The Form 4 facts do not strongly tilt positive or negative.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

EVP, Clinical Development

Officer YesDirector No10% NoOther No
Footnotes & amended
  1. F1

    The Ordinary Shares may be represented by American Depositary Shares ("ADS"). Each 10 ADSs represent 23 Ordinary Shares of the Issuer.

  2. F2

    Reported securities are represented by 4,079 ADSs.

  3. F3

    Each restricted stock unit ("RSU") represents a contingent right to receive one ADS.

  4. F4

    Reported securities are represented by 133,688 ADSs.

  5. F5

    Reported securities are represented by 1,427 ADSs.

  6. F6

    Reported sales price represents the converted sales price of the ADSs of $1.8186.

  7. F7

    Reported securities are represented by 132,261 ADSs.

  8. F8

    Reported securities represent ADSs.

  9. F9

    On May 30, 2024, the Reporting Person was granted 65,270 RSUs. The RSUs vested or shall vest over four years, with one-fourth vesting on the first anniversary of the grant date and the balance vesting…

Original filing · 0002114309-26-000007
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

NBP